Drug helps reprogram macrophage immune cells, suppress prostate and bladder tumor growth

A novel therapy that reprograms immune cells to promote antitumor activity helped shrink hard-to-treat prostate and bladder cancers in mice, according to new research.

Related Keywords

United States ,Johns Hopkins University ,Maryland ,American ,Robertd Leone ,Kennethm Adusei ,Jonathan Powell ,Barbara Slusher ,Xiaoxu Wang ,Liang Zhao ,Ada Tam Srinivasan Yegnasubramanian ,Alexj Lee ,Debebe Theodros ,Karaa Lombardo ,Thomasr Nirschl ,Edwardj Pearce ,Monali Praharaj ,Jelani Zarif ,Roberte Meyerhoff ,Alokk Singh ,Raekwona Williams ,Elizabetha Thompson ,Lauraa Sena ,Johns Hopkins ,National Institutes Of Health Cancer Institute ,Cancer Immunology Research ,American Association For Cancer Research ,Bloomberg ,Maryland Cigarette Restitution Fund ,Dracen Pharmaceuticals ,Prostate Cancer Foundation Young Investigator Award ,Kimmel Institute For Cancer Immunotherapy ,Bloomberg Kimmel Institute For Cancer Immunotherapy ,American Association ,Endowed Professor ,Johns Hopkins Drug Discovery ,Kimmel Institute ,Yifan Shen ,Ada Tam ,Srinivasan Yegnasubramanian ,Jesse Alt ,Rana Rais ,National Institutes ,National Cancer Institute ,